HSIC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HSIC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Henry Schein's shares outstanding for the quarter that ended in Dec. 2024 was 124 Mil.
Henry Schein's quarterly shares outstanding declined from Sep. 2024 (125 Mil) to Dec. 2024 (124 Mil). It means Henry Schein bought back shares from Sep. 2024 to Dec. 2024 .
Henry Schein's annual shares outstanding declined from Dec. 2023 (129 Mil) to Dec. 2024 (124 Mil). It means Henry Schein bought back shares from Dec. 2023 to Dec. 2024 .
The historical data trend for Henry Schein's Shares Outstanding (EOP) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Henry Schein Annual Data | |||||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||||
Shares Outstanding (EOP) | Get a 7-Day Free Trial |
![]() |
![]() |
142.46 | 137.15 | 131.79 | 129.25 | 124.16 |
Henry Schein Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
Shares Outstanding (EOP) | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
129.25 | 128.48 | 127.08 | 125.15 | 124.16 |
For the Medical Distribution subindustry, Henry Schein's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Distribution industry and Healthcare sector, Henry Schein's Shares Outstanding (EOP) distribution charts can be found below:
* The bar in red indicates where Henry Schein's Shares Outstanding (EOP) falls into.
Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.
Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.
Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.
Henry Schein (NAS:HSIC) Shares Outstanding (EOP) Explanation
A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.
Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.
Be Aware
Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.
Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.
If net earnings is less than 10%, likely to be in a highly competitive business.
Thank you for viewing the detailed overview of Henry Schein's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.
Bradford C Connett | officer: CEO, NA Distribution Group | C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747 |
Philip A Laskawy | director | 9 CREAMER HILL ROAD, GREENWICH CT 06831 |
Kurt P Kuehn | director | C/O HENRY SCHEIN, INC, 135 DURYEA ROAD, MELVILLE NY 11747 |
Michael S Ettinger | officer: SVP, General Counsel, Sec. | C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747 |
Lorelei Mcglynn | officer: SVP, Global HR & Fin. Oper. | C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747 |
Mark E Mlotek | director, officer: SVP, Corp Bus Dev Group | C/O HENRY SCHEIN INC, 135 DURYEA RD, MELVILLE NY 11747 |
Walter Siegel | officer: Senior VP & General Counsel | C/O HENRY SCHEIN, INC, 135 DURYEA RD, MELVILLE NY 11747 |
James P Breslawski | director, officer: Executive Vice President | C/O HENRY SCHEIN INC, 135 DURYEA RD, MELVILLE NY 11747 |
Stanley M Bergman | director, officer: President and CEO | C/O HENRY SCHEIN INC, 135 DURYEA ROAD, MELVILLE NY 11747 |
Brous David B Jr | officer: CEO, Strategic Business Group | C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747 |
Gerald A Benjamin | director, officer: Executive V.P and CAO | C/O HENRY SCHEIN, INC, 135 DURYEA RD, MELVILLE NY 11747 |
Ronald N. South | officer: SVP & Chief Financial Officer | C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747 |
Scott Philip Serota | director | C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747 |
Reed Vaughn Tuckson | director | C/O UNITEDHEALTH GROUP INCORPORATED, 9900 BREN ROAD EAST, MINNETONKA MN 55123 |
Steven Paladino | director, officer: Executive V.P. and CFO | C/O HENRY SCHEIN INC, 135 DURYEA RD, MELVILLE NY 11747 |
From GuruFocus
By Business Wire • 01-14-2025
By GuruFocus News • 02-28-2025
By Business Wire • 01-29-2025
By GuruFocus News • 02-25-2025
By GuruFocus News • 01-29-2025
By Business Wire • 02-12-2025
By GuruFocus News • 01-29-2025
By GuruFocus News • 02-26-2025
By GuruFocus News • 03-14-2025
By GuruFocus News • 02-26-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.